Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mint Med vs Wisp

Mint Med
Graded #22

Higher grade

vs+20.299999999999997
Wisp
Graded #243

Lower grade

The verdict

Mint Med takes it — 84.7/100 to 64.4/100.

Mint Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low both-molecule pricing ($117/$159) and verified — but only 36 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMint Med +40
90
50
Dose & formulationMint Med +4
80
76
Clinical oversightMint Med +3
85
82
Labs & monitoringMint Med +30
83
53
FulfillmentMint Med +16
82
66
Contract termsMint Med +31
86
55
Mint Med · left barWisp · right bar

The numbers

MetricMint MedWisp
WeighScore84.7/10064.4/100
GradeBC
Scorecard rank#22#243
Semaglutide$117/mo$225/mo (compounded oral)
Tirzepatide$159/moNot disclosed
Coverage36 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Mint Med

Graded #22 · B

Strengths

  • $117 sema / $159 tirz
  • LegitScript-verified
  • Both molecules

Where it loses points

  • Only 36 states
  • Injection-only
  • Monitoring detail sparse
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard